Gladius Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,662
| Closed | -$387K | – | 109 |
|
|
2025
Q4 | $344K | Buy |
+1,662
| New | +$329K | 0.02% | 92 |
|
|
2025
Q3 | – | Sell |
-1,300
| Closed | -$223K | – | 107 |
|
|
2025
Q2 | $199K | Sell |
1,300
-4,727
| -78% | -$727K | 0.07% | 63 |
|
|
2025
Q1 | $1,000K | Sell |
6,027
-6,376
| -51% | -$998K | 0.27% | 58 |
|
|
2024
Q4 | $1.79M | Sell |
12,403
-341
| -3% | -$52.8K | 0.19% | 61 |
|
|
2024
Q3 | $2.07M | Sell |
12,744
-2,520
| -17% | -$402K | 0.25% | 53 |
|
|
2024
Q2 | $2.23M | Buy |
15,264
+10,544
| +223% | +$1.57M | 0.27% | 41 |
|
|
2024
Q1 | $747K | Sell |
4,720
-682
| -13% | -$109K | 0.25% | 87 |
|
|
2023
Q4 | $847K | Sell |
5,402
-26,972
| -83% | -$4.14M | 0.13% | 92 |
|
|
2023
Q3 | $5.04M | Buy |
+32,374
| New | +$5.34M | 0.21% | 84 |
|
|
2023
Q2 | – | Sell |
-18,169
| Closed | -$2.93M | – | 419 |
|
|
2023
Q1 | $2.82M | Buy |
18,169
+13,234
| +268% | +$2.14M | 0.16% | 69 |
|
|
2022
Q4 | $872K | Sell |
4,935
-14,131
| -74% | -$2.44M | 0.06% | 80 |
|
|
2022
Q3 | $3.12M | Buy |
19,066
+16,353
| +603% | +$2.77M | 0.14% | 64 |
|
|
2022
Q2 | $482K | Buy |
2,713
+1,338
| +97% | +$238K | 0.03% | 124 |
|
|
2022
Q1 | $244K | Sell |
1,375
-1,998
| -59% | -$340K | 0.02% | 143 |
|
|
2021
Q4 | $578K | Buy |
3,373
+3,200
| +1,850% | +$524K | 0.05% | 102 |
|
|
2021
Q3 | $28K | Buy |
173
+161
| +1,342% | +$27.5K | ﹤0.01% | 113 |
|
|
2021
Q2 | $2K | Buy |
+12
| New | +$1.99K | ﹤0.01% | 126 |
|
|
2020
Q4 | – | Sell |
-2,012
| Closed | -$297K | – | 176 |
|
|
2020
Q3 | $300K | Buy |
+2,012
| New | +$298K | 0.03% | 148 |
|
|
2020
Q2 | – | Sell |
-4,699
| Closed | -$617K | – | 68 |
|
|
2020
Q1 | $617K | Buy |
+4,699
| New | +$667K | 0.07% | 108 |
|
|
2019
Q4 | – | Sell |
-21,595
| Closed | -$2.93M | – | 189 |
|
|
2019
Q3 | $2.79M | Buy |
21,595
+12,313
| +133% | +$1.62M | 0.13% | 98 |
|
|
2019
Q2 | $1.29M | Sell |
9,282
-35,334
| -79% | -$4.89M | 0.08% | 84 |
|
|
2019
Q1 | $6.24M | Sell |
44,616
-46,789
| -51% | -$6.27M | 0.34% | 54 |
|
|
2018
Q4 | $11.8M | Buy |
91,405
+86,715
| +1,849% | +$12.1M | 0.57% | 41 |
|
|
2018
Q3 | $648K | Sell |
4,690
-5,613
| -54% | -$746K | 0.06% | 47 |
|
|
2018
Q2 | $1.25K | Buy |
+10,303
| New | +$1.29M | 0.13% | 45 |
|
Other funds holding JNJ
VCM
VPM
Gladius Capital Management's JNJ Position: Q1 2026 in Review
Gladius Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,662 shares — an estimated $387K sold.
Gladius Capital Management first reported a position in JNJ in Q2 2018 and held it in 25 quarters. The position peaked at $11.8M in Q4 2018. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Gladius Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- Gladius Capital Management sold 1,662 Johnson & Johnson shares in Q1 2026, an estimated $387K.
- Gladius Capital Management first reported a position in Johnson & Johnson in Q2 2018 and held it in 25 quarters.
- Gladius Capital Management's Johnson & Johnson position peaked at $11.8M in Q4 2018.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.